Article Text

Download PDFPDF
Growth monitoring following traumatic brain injury
  1. R J Moon1,
  2. P Wilson2,
  3. F J Kirkham3,
  4. J H Davies1
  1. 1
    Paediatric Endocrinology, Southampton University Hospitals NHS Trust, Southampton, UK
  2. 2
    Paediatric Intensive Care Unit, Southampton University Hospitals NHS Trust, Southampton, UK
  3. 3
    Paediatric Neurology, Southampton University Hospitals NHS Trust, Southampton, UK
  1. Correspondence to Dr J H Davies, Child Health Directorate, MP 43, Southampton University Hospital Trust, Tremona Road, Southampton SO16 3JE, UK; justin.davies{at}


Hypopituitarism is an important consequence of traumatic brain injury (TBI). Growth monitoring can be used as an indicator of pituitary function in children. A retrospective audit of case notes of 123 children who required intensive care unit admission with TBI found that only 71 (33%) of 212 attendances in 38 of 85 children followed up had documented height and weight measurements. Children were reviewed in 11 different specialty clinics, which showed a wide variation in the frequency of growth monitoring. Serial growth measurements were available for only 22 patients (17%), which showed a reduction in height standard deviation scores (0.17 (SD 0.33), p = 0.017) over a mean follow-up period of 25.2 (SD 21.6) months. In conclusion, growth monitoring following TBI was poorly performed in this cohort, highlighting the need for a co-ordinated approach by primary and secondary care and all departments in tertiary centres involved in the follow-up of children with TBI.

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.


  • Competing interests Dr JH Davies has previously received research funding from Pfizer and Novo Nordisk.